Exscientia Plc (EXAI) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Exscientia Plc has committed to an irrevocable undertaking favoring the acquisition of its issued and to-be-issued share capital by Recursion Pharmaceuticals, Inc. The agreement includes strict terms ensuring Exscientia’s shareholders will not entertain other offers and will vote in support of the acquisition. The deal is set to proceed either through a court-sanctioned scheme of arrangement or a takeover offer, as detailed in the transaction agreement.
For further insights into EXAI stock, check out TipRanks’ Stock Analysis page.
